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A RESPONSE TO: DEADLY RADON IN MONTANA?
Laura S. Larsson, PhD, MPH, RN  Montana State University
Dr. Hart intended to answer the question of whether or not radon is
deadly in Montana. Instead he answered the question, “Do
Environmental Protection Agency (EPA) county zone designations cor-
relate to statistically different rates of lung cancer deaths in Montana?”
Based on a non-significant student t-test comparing mean cancer mortal-
ity for EPA zone 1 and 2 designated counties, Dr. Hart concluded the
“notion” that radon is deadly in Montana should be questioned. Dr.
Hart’s analysis is flawed.
Dr. Hart used the age-adjusted mortality rates from the National
Cancer Institute (2010a) but excluded lung cancer deaths for individuals
65 years and older. Excluding data from the full range required justifica-
tion conceptually, clinically, and analytically. Figure 1 illustrates the
Montana counties with non-suppressed cases when the age restriction was
removed. In addition, the mortality rates were not adjusted for smoking
rate, environmental tobacco smoke, air-pollution particulate matter days,
use of wood as a primary indoor heating source, medical sources of ion-
izing radiation, or access to care—all confounders for a meaningful analy-
sis. I would direct Dr. Hart to the “interpret” link on the National Cancer
Institute webpage for their explanation for geographic variations in can-
cer mortality rates (National Cancer Institute, 2010b). Despite these ana-
lytical errors, Dr. Hart does raise an interesting question about the accu-
racy of the EPA zone designations.
The EPA zone designations were derived from a prediction model
based on indoor radon measurements, local geology, aerial radioactivity,
soil permeability, and foundation type. Assigning each county into one of
three zones for radon potential was a process required by the Indoor
Radon Abatement Act of 1988 (EPA 2010). Zone 1 is the highest desig-
nation with a predicted indoor radon screening level average of greater
than 4 picocuries per liter (pCi/L); the current EPA action level. Zone 2
is defined as moderate potential with an average indoor radon concen-
tration between 2 and 4 pCi/L. Zone 3 is defined as low potential with an
average indoor radon concentration less than 2 pCi/L. Forty-nine of
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Montana’s 56 counties are designated as zone 1 and seven are designated
as zone 2. Therefore, none of the counties in Montana could be
described, as Dr. Hart did, as low radon counties. It is important to note
that these designations are guidelines and the U.S. Surgeon General and
the EPA recommended that every home should be tested regardless of
geographic location (EPA 2010).
The broader issue Dr. Hart engaged was the issue of lung cancer mor-
tality from radon. The President’s Cancer Panel (2009) recently reported
that the cancer risk attributable to residential radon exposure has been
clearly demonstrated and must be better addressed (p. xiv). The Panel
recommended the EPA consider lowering its current radon action level.
It is noteworthy that the World Health Organization (WHO) recently set
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their recommended action level to the equivalent of 2.7 pCi/L (WHO
2009). I would direct Dr. Hart to the list of distinguished references pro-
vided by both the President’s Cancer Panel as well as the World Health
Organization regarding the cumulative evidence in support of their rec-
ommendations.
Lung cancer, and potentially leukemia (Smith et al. 2007), skin, stom-
ach, and liver cancers, result from protracted radon exposure (Pawel and
Puskin 2003). Lung cancer is now the leading cause of cancer death
among American women and radon exposure is the leading cause of lung
cancer for people who do not smoke (Centers for Disease Control and
Prevention 2010). Reducing preventable radon exposure is a goal com-
mon to the Healthy People 2010 (U.S. Department of Health and Human
Services 20010b) and 2020 Programs (U.S. Department of Health and
Human Services 2010a), WHO (2009), the President’s Cancer Panel
(2009) and the Montana Cancer Control Coalition (2009). It is time for
the allied health-care community to quiet the debate about the carcino-
genicity of radon and focus instead on initiatives to reduce or eliminate
preventable, unintentional radon exposure.
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